Kies je regio

Selecteer de regio die het beste past bij je locatie of voorkeuren.

International

Kies je sitetaal

Deze instelling regelt de taal van de gebruikersinterface, inclusief knoppen, menu's en alle tekst op de site. Selecteer je voorkeurstaal voor de beste browse-ervaring.

Kies de talen voor vacatures

Selecteer de talen voor vacatures die je wilt zien. Deze instelling bepaalt welke vacatures aan jou worden getoond.

KOTAI Biotechnologies, Inc

Ibaraki, Japan

Maak een e-mailalert aan

Website bezoeken

Over de werkgever

The repertoire of immune cell receptors has direct consequences for resistance to infection, autoimmune disease and cancer.

KOTAI’s platform technology can reveal the structure and function of immune cell receptors with unprecedented resolution from a routine blood sample.

Our vision is to provide technology that reveals the functional state of the immune system at the molecular level.

The only high-throughput structural modeling and analysis platform for immune cell sequences.

ACCURACY
Our B and T cell receptor modeling technology is the most accurate available. Typical errors for backbone residues is less than 1 Angstrom.
SPEED
The current version of Repertoire Builder produces 1,000 models per day on a single processor, and scales linearly with the number of processors.
SOPHISTICATION
Using sequence and structural features from B or T cell receptor models, Repertoire Builder can group receptors according to their target epitopes, revealing the functional landscape of a donor and quantifying differences between donors.